S.N | Author/year | Population | Sample size | TP | FP | FN | TN | Index test | RDT target antigen | Reference test |
---|---|---|---|---|---|---|---|---|---|---|
1 | Hailu et al. (2014) | Malaria suspected patients | 398 | 201 | 4 | 0 | 193 | RDT | HRP-2 & Pv-pLDH | Microscopy |
2 | Moges et al. (2012) | Febrile patients | 254 | 95 | 5 | 9 | 145 | RDT | HRP-2 and pan pLDH | Microscopy |
3 | Eticha et al. (2020) | Febrile patients | 160 | 76 | 4 | 4 | 76 | RDT | HRP-2 and Pv-pLDH | Microscopy |
4 | Woyessa et al. (2013a) | Febrile patients (household survey) | 796 | 79 | 24 | 8 | 693 | RDT | HRP-2 and Pv-pLDH | Microscopy |
5 | Woyessa et al. (2013b) | Febrile patients (Health center) | 1598 | 375 | 208 | 17 | 1015 | RDT | HRP-2 and Pv-pLDH | Microscopy |
6 | Tadesse et al. (2016) | Febrile patients | 374 | 265 | 2 | 7 | 100 | RDT | HRP-2 and pan pLDH | Microscopy |
7 | Feleke et al. (2017) | Febrile patients | 320 | 40 | 3 | 1 | 276 | RDT | HRP-2 and pan pLDH | Microscopy |
8 | Alemayehu et al. (2020a) | Malaria suspected patients | 406 | 103 | 20 | 4 | 279 | RDT | HRP-2 | Microscopy |
9 | Alemyehu et al. (2020b) | Malaria suspected | 406 | 95 | 3 | 12 | 269 | RDT | PfLDH | Microscopy |
10 | Golassa et al. (2015a) | Asymptomatic individuals | 1094 | 46 | 44 | 8 | 996 | RDT | HRP-2 & Pv-pLDH | Microscopy |
11 | Tadesse et al. (2001) | Febrile patients | 100 | 45 | 4 | 5 | 46 | RDT | HRP-2 & Pv/Pf-pLDH | Microscopy |
12 | Mohammed et al. (2012) | Febrile patients | 1293 | 111 | 8 | 7 | 32 | RDT | HRP-2 | Microscopy |
13 | Mekonnen et al. (2010) | Febrile patients | 240 | 115 | 0 | 5 | 120 | RDT | HRP-2 & Pv-pLDH | Microscopy |
14 | Bayisa et al. (2015) | Febrile patients | 384 | 97 | 11 | 10 | 266 | RDT | HRP-2 & Pv-pLDH | Microscopy |
15 | Abebe et al. (2018) | Febrile patients | 417 | 149 | 2 | 7 | 259 | RDT | HRP-2 & pan pLDH | Microscopy |
16 | Chanie et al. (2011) | Febrile patients | 1092 | 223 | 20 | 3 | 846 | RDT | HRP-2 & Pv-pLDH | Microscopy |
17 | Sharew et al. (2009a) | Febrile patients | 668 | 158 | 25 | 1 | 484 | RDT | HRP-2 | Microscopy |
18 | Sharew et al. (2009b) | Febrile patients | 668 | 314 | 17 | 2 | 335 | RDT | HRP-2 & Pv-pLDH | Microscopy |
19 | Endeshaw et al. (2012) | Febrile patients | 1997 | 376 | 64 | 99 | 1454 | RDT | HRP-2 & pan pLDH | Microscopy |
20 | Tekeste et al. (2012) | Febrile patients | 400 | 200 | 11 | 10 | 179 | RDT | HRP-2 | Microscopy |
21 | Morankar e.al (2011) | Febrile patients | 929 | 40 | 5 | 3 | 881 | RDT | HRP-2 | Microscopy |
22 | Tegegne et al. (2017a) | Symptomatic and asymptomatic | 330 | 31 | 0 | 5 | 294 | RDT | HRP-2 and pan pLDH | Microscopy |
23 | Ashton et al. (2010a) | Febrile patients | 2383 | 526 | 190 | 26 | 1641 | RDT | HRP-2 and pan pLDH | Microscopy |
24 | Beyene et al. (2016) | Febrile patients | 977 | 135 | 33 | 26 | 783 | RDT | HRP-2 and Pv/Pf-pLDH | Microscopy |
25 | Ashton et al. (2010b) | Febrile patients | 2383 | 529 | 208 | 23 | 1623 | RDT | HRP-2 and pan pLDH | Microscopy |
26 | Ashton et al. (2010c) | Febrile patients | 2383 | 525 | 194 | 27 | 1637 | RDT | HRP-2 & pan-aldolase | Microscopy |
27 | Alemayehu et al. (2020c) | Febrile patients | 406 | 104 | 19 | 32 | 250 | RDT | HRP-2 | PCR |
28 | Alemayehu et al. (2020d) | Febrile patients | 406 | 95 | 3 | 41 | 266 | RDT | PfLDH | PCR |
29 | Golassa et al. (2015c) | Febrile patients | 94 | 61 | 18 | 8 | 7 | RDT | HRP-2 & Pv-pLDH | PCR |
30 | Tegegne et al. (2017b) | Symptomatic and asymptomatic | 330 | 30 | 1 | 51 | 248 | RDT | HRP-2 and pan pLDH | PCR |
31 | Getnet et al. (2015) | Asymptomatic individuals | 359 | 61 | 19 | 37 | 243 | RDT | HRP-2 and pan pLDH | PCR |
32 | Golassa et al. (2013b) | Clinical & sub-clinical patients | 500 | 80 | 20 | 77 | 323 | RDT | HRP-2 and Pv-pLDH | PCR |
33 | Alemu et al. (2014) | Malaria suspected patients | 297 | 183 | 5 | 39 | 75 | Microscopy | NA | PCR |
34 | Alemayehu et al. (2020e) | Malaria suspected patients | 406 | 105 | 2 | 31 | 267 | Microscopy | NA | PCR |
35 | Golossa et al. (2015b) | Asymptomatic individuals | 94 | 42 | 5 | 27 | 20 | Microscopy | NA | PCR |
36 | Sema et al. (2015a) | Febrile patients | 82 | 30 | 0 | 1 | 51 | Microscopy | NA | PCR |
37 | Golassa et al. (2013a) | Clinical & sub-clinical patients | 454 | 49 | 6 | 77 | 323 | Microscopy | NA | PCR |
38 | Díaz et al. (2015) | Malaria suspected patients | 1209 | 604 | 23 | 184 | 398 | Microscopy | NA | PCR |
39 | Girma et al. (2018b) | Asymptomatic individuals | 562 | 118 | 7 | 0 | 437 | LAMP | NA | Microscopy |
40 | Sema et al. (2015c) | Malaria suspected patients | 82 | 30 | 8 | 0 | 44 | LAMP | NA | Microscopy |
41 | Tegegneet al. (2017a) | Symptomatic and asymptomatic | 87 | 10 | 5 | 0 | 72 | LAMP | NA | Microscopy |
42 | Girma et al. (2018a) | Asymptomatic individuals | 562 | 121 | 4 | 0 | 437 | LAMP | NA | PCR |
43 | Sema et al. (2015b) | Febrile patients | 82 | 31 | 7 | 0 | 44 | LAMP | NA | PCR |
44 | Tegegne et al. (2017b) | Symptomatic and asymptomatic | 87 | 10 | 5 | 0 | 72 | LAMP | NA | PCR |
45 | Tadesse G. et al. (2020a) | Symptomatic and asymptomatic | 435 | 6 | 0 | 3 | 426 | RDT | NA | LAMP |
46 | Tadesse G. et al. (2020b) | Symptomatic and asymptomatic | 435 | 5 | 0 | 4 | 426 | Microscopy | NA | LAMP |